{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:01:40Z","timestamp":1767772900864,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301028 and 81171126"],"award-info":[{"award-number":["81301028 and 81171126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jneuroim.2016.08.015","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T16:40:17Z","timestamp":1471884017000},"page":"66-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Serum concentration of CD40L is elevated in inflammatory demyelinating diseases"],"prefix":"10.1016","volume":"299","author":[{"given":"Xiaonan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-7612","authenticated-orcid":false,"given":"Xueqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jneuroim.2016.08.015_bb9000","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1212\/NXI.0000000000000104","article-title":"Lymphocytes in neuromyelitis optica","volume":"2","author":"Bennett","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.jneuroim.2016.08.015_bb9005","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.metabol.2015.05.001","article-title":"Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate","volume":"64","author":"Carrieri","year":"2015","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.jneuroim.2016.08.015_bb0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10072-013-1481-y","article-title":"The complement and immunoglobulin levels in NMO patients","volume":"35","author":"Chen","year":"2014","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.08.015_bb0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/clin.1997.4391","article-title":"Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells","volume":"84","author":"Faure","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"6","key":"10.1016\/j.jneuroim.2016.08.015_bb0015","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1073\/pnas.93.6.2499","article-title":"CD40\u2013CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis","volume":"93","author":"Gerritse","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.jneuroim.2016.08.015_bb0020","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI200319301","article-title":"Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154\u2013CD40 interactions","volume":"112","author":"Grammer","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.jneuroim.2016.08.015_bb0030","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/eji.201470045","article-title":"B cells in multiple sclerosis: good or bad guys?: an article for 28 May 2014 \u2014 World MS Day 2014","volume":"44","author":"Hoffmann","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2016.08.015_bb0040","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1073\/pnas.0810769106","article-title":"CD40\u2013CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells","volume":"106","author":"Iezzi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jneuroim.2016.08.015_bb9010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1468-1331.2001.00232.x","article-title":"Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis","volume":"8","author":"Jensen","year":"2001","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2016.08.015_bb0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/clim.2001.5172","article-title":"Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus","volume":"103","author":"Katsiari","year":"2002","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2016.08.015_bb0055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaneurol.2013.3071","article-title":"A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder","volume":"70","author":"Kim","year":"2013","journal-title":"JAMA Neurol."},{"issue":"9451","key":"10.1016\/j.jneuroim.2016.08.015_bb0060","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"Serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2016.08.015_bb0065","series-title":"Increased Memory Th17 Cells in Patients with Neuromyelitis Optica and Multiple Sclerosis","first-page":"155","volume":"234","author":"Li","year":"2011"},{"key":"10.1016\/j.jneuroim.2016.08.015_bb0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/00365517709091498","article-title":"Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis","volume":"37","author":"Link","year":"1977","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jneuroim.2016.08.015_bb0075","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"issue":"32","key":"10.1016\/j.jneuroim.2016.08.015_bb0080","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2016.08.015_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2014.07.001","article-title":"Complement activation in patients with neuromyelitis optica","volume":"274","author":"Nytrova","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2016.08.015_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.08.015_bb0095","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2016.08.015_bb0100","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.424741","article-title":"Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord","volume":"203","author":"Prineas","year":"1979","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2016.08.015_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"Rostami","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2016.08.015_bb0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"issue":"8","key":"10.1016\/j.jneuroim.2016.08.015_bb0115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/thy.1999.9.749","article-title":"CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases","volume":"9","author":"Smith","year":"1999","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.jneuroim.2016.08.015_bb0120","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jocn.2011.01.031","article-title":"Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse","volume":"18","author":"Wang","year":"2011","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.08.015_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2016.08.015_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2013.04.021","article-title":"IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis","volume":"261","author":"Xu","year":"2013","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281630203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281630203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:28:16Z","timestamp":1759048096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281630203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":26,"alternative-id":["S016557281630203X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.08.015","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum concentration of CD40L is elevated in inflammatory demyelinating diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}